Healthcare PM Product Sense: Solving Real Problems at Epic and 23andMe

The candidates who can articulate a clear problem-solution fit in healthcare don’t get hired because they name 10 features — they get hired because they identify which levers move outcomes in a system governed by clinicians, compliance, and long feedback loops. At Epic, a product sense interview isn’t about your favorite app; it’s about whether you can design a clinician-facing alert that reduces alert fatigue while improving sepsis detection. At 23andMe, it’s not about consumer funnels — it’s about how you’d redesign the genetic risk report to avoid misinterpretation without sacrificing engagement. Most candidates fail because they treat healthcare like consumer tech. The ones who pass treat it like a high-stakes coordination problem.

This isn’t a test of domain knowledge. It’s a test of judgment under constraints.

Who This Is For

You’re a product manager with 2–8 years of experience, likely in tech, looking to transition into healthcare. You’ve read about Epic’s campus in Verona, WI, or seen 23andMe’s ancestry ads, and assumed the PM work mirrors Silicon Valley. It doesn’t. You need this if you’ve been ghosted after a product sense round, or if your mock interviews reveal that you “understand the user” but miss the systemic tradeoffs. This is for candidates preparing for PM roles at regulated, data-sensitive companies where a bad product decision can delay care or trigger FDA scrutiny. If your preparation stops at “user pain points,” you’re not ready.

What Does Product-Sense Mean in Healthcare, Really?

Product-sense in healthcare isn’t about empathy or brainstorming — it’s about constraint navigation. At a debrief last year for an Epic senior PM role, the committee rejected a candidate who designed a beautiful patient portal redesign. Why? Because the prototype assumed real-time data sync across 250 hospital systems — technically impossible under current interoperability standards. The problem wasn’t the idea. It was the ignorance of HL7 FHIR adoption curves.

Healthcare product-sense means you can’t just ask, “What does the user want?” You must ask:

Who pays? (Clinician, hospital admin, patient, insurer)
Who approves? (Legal, compliance, ethics board)
Who acts? (Nurse, primary care physician, specialist)
Who suffers if it fails? (Patient, provider, institution)

At 23andMe, during a product sense exercise on “improving BRCA risk communication,” one candidate proposed a chatbot. Another proposed a tiered disclosure system: raw data locked, intermediate risk flags visible only after genetic counseling opt-in, and final risk scores presented with clinical context. The second passed. Not because it was more “innovative,” but because it respected the liability model.

Not a test of clinical knowledge. But a test of how you weight risk when users can’t undo a misinterpretation.

In a Q3 23andMe HC meeting, a hiring manager said: “We don’t need more features. We need fewer decisions that require a PhD to understand.” That’s the bar.

How Do Epic and 23andMe Evaluate Product-Sense Differently?

Epic evaluates product-sense through workflow fidelity. 23andMe evaluates it through risk framing.

At Epic, the interview simulates a clinician’s day. You’re given a problem like: “Nurses miss 40% of sepsis alerts. Fix it.” A weak candidate suggests “reduce the number of alerts.” A strong candidate asks:

- What’s the current false positive rate?

- Are alerts appearing in the nurse’s primary workflow (EMR) or secondary (email)?

- What’s the penalty for a missed alert vs. a false one?

In a real debrief, a candidate proposed contextual alerting: only trigger sepsis alerts during shift handoffs, when nurses review summaries. The committee paused. “How does that affect detection lag?” One engineer calculated: average 22 minutes delay. “Is that acceptable?” The clinical reviewer said: “For low-risk patients, yes. For ICU, no.” The candidate had segmented by risk tier and proposed different thresholds. He was hired.

At 23andMe, the same problem — “reduce false alarms” — is approached differently. The user isn’t a professional. They’re a consumer with a $99 kit and Google. In a 2023 interview, a candidate was asked: “How would you redesign the Parkinson’s risk report?” Weak response: “Make it simpler.” Strong response: “Deprecate the binary ‘increased risk’ label. Replace it with population-relative percentiles, a timeline of research maturity, and a forced click-through to a video explainer before showing the result.”

Why? Because in a study of 12,000 users, 68% who saw “increased risk” believed they would definitely develop Parkinson’s. That’s a product failure — not a user education failure.

Epic cares if the system works reliably under stress. 23andMe cares if the user acts correctly after emotional arousal.

Not about solving the surface problem. But about aligning the solution with the decision-making hierarchy.

In a joint HC review at 23andMe, a candidate was dinged not for her solution, but because she didn’t quantify the emotional risk. One interviewer said: “You treated this like a UI problem. It’s a behavioral risk problem.”

What Frameworks Actually Work in Healthcare Product-Sense Interviews?

The standard consumer PM frameworks (CIRCLES, AARM) fail in healthcare because they assume short feedback loops and reversible decisions. In healthcare, you need a framework that forces risk accounting.

At Epic, we use the CLIN-RISK framework in training:

Consequence (clinical impact: morbidity, mortality)
Liability (legal, regulatory exposure)
Intervention tier (who acts, and how much training do they have?)
Noise (false positives/negatives, alert fatigue)
Rollout path (phased by facility type, opt-in vs. mandate)
Interop constraint (data availability, standards compliance)
Scalability (across 10 vs. 1,000 hospitals)
Keepout (what does this prevent us from doing later?)

In a mock interview, a candidate used CLIN-RISK to redesign a medication reconciliation tool. Instead of listing features, he scored each option:

Auto-fill from pharmacy records: high consequence if wrong, low noise, high interop constraint
Nurse verification step: increases friction, reduces liability, scalable only with staffing

He recommended a hybrid: auto-fill with clinician override flag, but only where pharmacy data is >90% complete. The interviewer nodded. “That’s how we shipped it.”

At 23andMe, the DECIDE framework is preferred:

Decision burden (how much must the user interpret?)
Emotional valence (does this trigger anxiety, false reassurance?)
Confirmability (can the result be validated clinically?)
Intervention availability (is there a next step?)
Decision latency (how urgent is action?)
Ecosystem alignment (does this fit with genetic counseling networks?)

In a real 23andMe interview, a candidate used DECIDE to argue against releasing a new Alzheimer’s polygenic risk score. “Decision burden: high. Emotional valence: severe anxiety with no intervention. Confirmability: low — not diagnostic. Intervention availability: none. So even if accuracy is 80%, we shouldn’t release.” The hiring manager said: “We killed that project last quarter for the same reasons.”

Not about memorizing frameworks. But about using them to expose tradeoffs the business can’t ignore.

Weak candidates apply frameworks like checklists. Strong candidates use them to justify not building something.

How Do You Prepare for a Real Product-Sense Interview at These Companies?

You don’t practice by brainstorming random features. You simulate deliberation under institutional gravity.

At Epic, interviewers pull real tickets from Jira. One used in 2022: “ICU doctors say they don’t trust the AI sepsis predictor.” Candidates had 15 minutes to propose a solution. The top performer didn’t suggest retraining the model. He proposed:

Add a “confidence meter” to the UI, tied to input data completeness
Show model inputs (e.g., lactate level trending up)
Allow clinicians to flag false positives, feeding a review queue
Publish monthly accuracy reports to build trust

Why it worked: it acknowledged that trust is a UX problem, not a model problem. In the debrief, the clinical reviewer said: “This matches how we actually got adoption in UW Health.”

At 23andMe, a common prompt is: “Users share genetic results on social media. How would you reduce harm?” Weak answers: “Add a warning.” Strong answers: design friction. One candidate proposed:

After viewing a high-risk result, users must wait 48 hours before sharing
Sharing is limited to one person (not public)
Shared links expire in 7 days
Recipients get a neutral landing page explaining limitations

This passed because it treated sharing as a clinical handoff, not a social feature.

Preparation must include:

10 hours studying real product decisions: Epic’s interoperability announcements, 23andMe’s FDA submission letters
5 mock interviews with PMs who’ve worked in regulated environments
1 walkthrough of a failed healthcare product (e.g., Theranos, IBM Watson Oncology) using CLIN-RISK or DECIDE

Work through a structured preparation system (the PM Interview Playbook covers healthcare product sense with verbatim debrief notes from Epic and 23andMe interviews, including red flags reviewers actually use).

Not about rehearsing answers. But about building pattern recognition for what gets escalated.

In a debrief, a hiring manager said: “She didn’t give the ‘best’ answer. But she asked the first three questions our safety committee would ask. That’s hiring.”

What Does the Interview Process Look Like at Epic and 23andMe?

At Epic:

Step 1: Recruiter screen (30 min) — filters for EMR familiarity
Step 2: Take-home product exercise (72 hours) — e.g., “Design a tool to reduce duplicate lab orders”
Step 3: Onsite (5 hours):
- 1 hour: product sense with senior PM
- 1 hour: technical deep dive (you’ll diagram APIs, explain FHIR)
- 1 hour: behavioral with engineering lead
- 1 hour: case with clinician reviewer
- 30 min: Q&A with hiring manager

The product sense round is graded by three reviewers: PM, engineer, clinician. All must approve. The clinician reviewer often overrides consensus. In Q2 2023, a candidate was rejected because the clinician said: “This alert would make me skip the EMR entirely.”

At 23andMe:

Step 1: Recruiter screen (20 min) — assesses genetics literacy
Step 2: Live case (60 min, remote) — e.g., “Improve the carrier status report for prenatal planning”
Step 3: Onsite (4 hours):
- 45 min: product sense with staff PM
- 45 min: data interpretation (given user study, explain implications)
- 45 min: ethics scenario (e.g., “Should we notify users of a newfound cancer risk without a doctor’s involvement?”)
- 45 min: cross-functional roleplay (you’re the PM, I’m legal — defend your launch plan)

The ethics round is the silent killer. In one HC meeting, a candidate aced product and data but failed ethics because she said: “Users should have the right to know.” The committee responded: “Our license to operate depends on not treating genetics like optional information. Intent doesn’t override harm.”

Offers are made only after legal and compliance sign-off. This isn’t a formality. In 2022, 3 offers were rescinded after compliance flagged risk in a candidate’s proposed rollout plan.

Not a sequence of evaluations. But a stress test of whether you’ll make the company’s risk appetite worse.

Mistakes to Avoid in Healthcare Product-Sense Interviews

Mistake 1: Solving the wrong problem by misidentifying the user

BAD: “Patients want faster access to test results.”
GOOD: “Primary care physicians are overwhelmed by patient messages after results drop. Our user is the PCP; the patient is the trigger.”
In a 23andMe interview, a candidate proposed pushing genetic results directly to users’ Apple Health. The interviewer stopped him: “Do you know how many PCPs in rural clinics have time to explain a 23andMe BRCA flag that shows up at midnight?” He didn’t. Rejected.

Mistake 2: Ignoring rollout constraints

BAD: “Let’s A/B test the new alert system in all 5,000 clinics.”
GOOD: “Pilot in 3 academic medical centers with existing research IRBs, measure clinician trust and false alert rates, then scale to community hospitals with slower opt-in.”
At Epic, one candidate suggested a nationwide rollout of a new EHR module. The engineer asked: “How do you handle facilities without 24/7 IT?” He hadn’t thought about it. The debrief note: “Lacks operational realism.”

Mistake 3: Treating healthcare data like tech data

BAD: “We’ll use engagement metrics to optimize the report.”
GOOD: “We’ll track downstream actions: % of high-risk users who schedule counseling, % of negative-result users who skip screening.”
At 23andMe, a candidate said: “We can increase time-on-page by adding animations.” The hiring manager replied: “We don’t want them spending more time. We want them acting correctly once.”

Not about avoiding mistakes. But about showing you’ve internalized that every decision is a risk decision.

In a debrief, a reviewer said: “Her solution was fine. But her success metrics would’ve incentivized harm. We can’t hire that.”

Preparation Checklist

Study 3 real product launches from each company: Epic’s MyChart enhancements, 23andMe’s FDA-cleared reports. Map them to CLIN-RISK or DECIDE.
Run 2 mocks with a healthcare PM — focus on pushback: “What if legal says no?” “What if clinicians revolt?”
Write 1 full response to a past prompt using a framework — then cut it in half. Clarity beats comprehensiveness.
Memorize 2 key constraints: For Epic, know FHIR adoption rates across hospital types. For 23andMe, know ACMG guidelines on incidental findings.
Work through a structured preparation system (the PM Interview Playbook covers healthcare product sense with real debrief examples from Epic and 23andMe, including how reviewers weight clinical vs. engagement outcomes).

This isn’t about quantity of prep. It’s about depth of realism.

The book is also available on Amazon Kindle.

Need the companion prep toolkit? The PM Interview Prep System includes frameworks, mock interview trackers, and a 30-day preparation plan.

About the Author

Johnny Mai is a Product Leader at a Fortune 500 tech company with experience shipping AI and robotics products. He has conducted 200+ PM interviews and helped hundreds of candidates land offers at top tech companies.

FAQ

Is clinical knowledge required for Epic’s product sense interview?

No. But you must understand clinical workflow. In a 2023 interview, a candidate without medical training passed by mapping the nurse’s shift timeline and identifying when alerts were disruptive. One with an MD failed because he focused on pathophysiology, not coordination cost. The issue isn’t knowledge — it’s whether you design for the actual work.

How technical does a 23andMe PM need to be in product sense rounds?

You won’t write code, but you must speak data limitations. In a live case, a candidate proposed real-time ancestry updates as new research emerged. The interviewer asked: “How often do reference genomes change?” He didn’t know. Rejected. You don’t need a genetics PhD, but you must know that data pipelines lag science by 12–18 months.

Can you reuse consumer PM frameworks for healthcare?

Only if you adapt them. CIRCLES fails because it doesn’t force risk accounting. A candidate last year used it to “satisfy user needs” for a mental health screening tool — but didn’t address false positives leading to unnecessary ER visits. The committee said: “You optimized for engagement, not safety. That’s disqualifying.” Not a framework problem — a judgment failure.